Murray Mark Christopher

SVP Murray Mark Christopher bought 2,017 shares of Celanese at $41.83 on 2025-08-14; stock down 69.2% from 52-week high; 3 other insiders also bought within 14 days.

Murray Mark Christopher, SVP – Acetyls, purchased 2,017 shares at $41.83 on 2025-08-14, increasing his holdings from 14,983 to 17,000 shares (+13.5%). The buy occurred as Celanese stock trades -69.2% from its 52-week high of $139.82 and -24.8% over the past 30 days, reflecting significant downward price pressure. Christopher's prior trades at Celanese show mixed timing: of 3 measurable 90-day outcomes at this ticker, 2 resulted in positive 90-day returns (+2.6%, +24.8%), though his most recent prior buy on 2025-03-07 delivered only +0.1% over 90 days despite an initial 30-day decline of -24.7%. A cluster pattern is present: 3 other insiders purchased within the past 14 days, suggesting coordinated assessment of value at depressed price levels. However, company fundamentals show contraction (revenue down 6.0% annually) and recent unprofitability, warranting caution about the strength of the buying signal.

SVP Murray Mark Christopher buys 1,479 shares of Celanese (CE) at $52.18, raising stake to 15,468 shares amid stock rebound from 52-week lows.

SVP Murray Mark Christopher purchased 1,479 shares at $52.18, increasing his holdings by 10.6% to 15,468 shares. The stock is currently trading at $53.93, up 23.1% over 30 days and up 6.7% over 90 days, yet remains 64.7% below its 52-week high of $152.87. In his prior two measurable same-ticker purchases, one buy (2024-03-08) returned +4.0% at 30 days while underperforming at 90 days (-5.9%), and a 2023 buy was more successful (+11.7% and +24.8%). His cross-ticker track record shows mixed timing, with an average 90-day return of +9.5% across 3 prior buys and a 50% win rate. The company faces headwinds: it is unprofitable (net income of $-21.0M in the latest quarter) with annual revenue declining 6.0%, though this purchase coincides with recent price appreciation rather than an absolute bottom.

SVP Acetyls Murray Mark Christopher bought 2,353 shares of CE at $54.45; stock now down -68.4% from 52-week high amid cluster buying by 3 other insiders in 14 days.

Murray Mark Christopher, SVP – Acetyls at Celanese, purchased 2,353 shares at $54.45 on 2025-03-07, expanding his holdings by 20.2% to 13,989 shares. The purchase occurs in a deteriorating price environment: the current price of $54.22 is -68.4% from the 52-week high of $171.86, and the stock has declined -20.3% over the past 30 days. Notably, 3 other insiders also bought within the past 14 days, forming a cluster buy pattern. Celanese's fundamentals remain strained—the company was unprofitable over its most recent full fiscal year, revenue contracted -6.0% year-over-year, and market cap stands at $5.9B. At the same ticker, Christopher's prior buy on 2024-03-08 delivered only +4.0% in 30 days and -5.9% in 90 days, showing mixed historical execution at this security. The convergence of depressed valuation, cluster accumulation, and unprofitable operations warrants close monitoring of management's confidence signals and near-term operational performance.